Health
The drug aprotinin inhibits entry of SARS-CoV2 in host cells, study finds – Science Daily
In order for the SARS-CoV2 virus to enter host cells, its ‘spike’ protein has to be cleaved by the cell’s own enzymes — proteases. The protease inhibitor aprotinin…
In order for the SARS-CoV2 virus to enter host cells, its “spike” protein has to be cleaved by the cell’s own enzymes — proteases. The protease inhibitor aprotinin can prevent cell infection, as scientists at Goethe University, the University of Kent and the Hannover Medical School have now discovered. An aprotinin aerosol is already approved in Russia for the treatment of influenza and could readily be tested for the treatment of COVID-19.The surface of the SARS-CoV-2 virus is studded with spike…
-
Noosa News13 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
General24 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
Noosa News22 hours agoNT cattle rustler fined almost $430k for stealing 116 head from neighbouring station
-
Business22 hours agoRevenue growth, profit margin pressures, and a $365m buyback